Evidence map›Paper›PMID 35734147›Full record

ArticleClinical, cosmetic and investigational dermatology2022

How to Define Mild to Severe Hidradenitis Suppurativa? A Simple New Tool Based on Latent Class Analysis of EPIVER Data Study.

Jean-Luc Perrot, François Maccari, Philippe Guillem, Anne-Claire Fougerousse, Aude Nassif, Nathalie Beneton, Elisa Cinotti, Céline Girard, Raphaelle Binois, Ziad Reguiaï and 1 more

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jean-Luc PerrotDepartment of Dermatology, University Hospital of Saint-Etienne, Saint-Etienne, France.
François MaccariResoVerneuil, Ville, France.
Philippe GuillemResoVerneuil, Ville, France.
Anne-Claire FougerousseResoVerneuil, Ville, France.ORCID 0000-0002-2850-867X
Aude NassifResoVerneuil, Ville, France.
Nathalie BenetonResoVerneuil, Ville, France.
Elisa CinottiResoVerneuil, Ville, France.
Céline GirardResoVerneuil, Ville, France.
Raphaelle BinoisResoVerneuil, Ville, France.
Ziad ReguiaïResoVerneuil, Ville, France.
ResoVerneuil group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Hidradenitis suppurativa (HS) is an inflammatory skin disease characterized by recurrent or chronic painful and suppurating lesions in the apocrine gland-bearing regions. The lack of knowledge about HS and its extremely heterogeneous clinical presentation, in terms of both lesion appearance and sites of involvement, frequently delay its diagnosis for several years. Objectives: in this study, using the latent class analysis, it was demonstrated that severity of HS could be evaluated not only with clinical or surgical characteristics but also with gender specificities. Patients and Methods: Clinical and sociodemographic data of HS patients were retrospectively analysed with the latent class method in order to create a classification tool of disease severity. Results: From the study of 1428 HS patients (544 men and 884 women), two classification models, depending on gender, were developed. Each classification model was composed of three distinct latent classes clearly identified and defined from mild-to-severe cases of HS. These classification models of HS severity were not distorted by patient ages and were coherent with Hurley stages but were more clinically precise. Conclusion: In this study, a convenient classification tool, useful for facilitating decision support in routine practice, has been developed. This tool could be used to define clinical subgroups within a study population.

Indexed as

classificationhidradenitis suppurativaHurley stagelatent classseverity

Identifiers

PMID35734147
PMCPMC9208478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.